Articles by Alison Bryant
Continuing a streak of donations to the field of vaccine research and biotech in general, the Bill & Melinda Gates Foundation granted $100,000 to an AgResearch scientist for research into a new tuberculosis vaccination method.
Scripps researchers develop methamphetamine vaccine
A team of scientists at the Scripps Research Institute saw promising results in a study of a vaccine against methamphetamine. With more than 430,000 users nationwide, methamphetamine has become one of the most common recreational drugs in the U.S.
Good news out of Canada in the search for an HIV vaccine: Scientists announced a vaccine candidate showed no adverse effects and significantly boosted immunity in human trials.
BiondVax and MonoSol Rx have joined forces to develop an oral delivery system for the universal flu vaccine M-001.
PsiOxus Therapeutics nabbed £1.7 million ($2.7 million) from the U.K. government-backed Biomedical Catalyst to start a Phase I/II clinical trial of its cancer vaccine.
Health officials have clashed over the effectiveness of a pricey malaria program intended to provide cheap drugs for poor patients.
A recent study shows close, repeated contact with a person with mumps can overwhelm the mumps vaccine.
Every flu season, doctors and pharmacists must stock up on the latest influenza vaccine to offer patients. Unlike other vaccines that provide decades worth of protection, the flu vaccine needs to be administered every year. But researchers are looking to change this.
The U.S. government doled out a contract worth £4 million ($6.4 million) to the U.K.'s Health Protection Agency to develop a next-generation anthrax vaccine. The project will be valued at £14 million ($22.6 million) if all milestones are met.
A new study shows the influenza vaccine protects against more than just the flu--it defends against heart attacks.